NEW YORK, Feb. 22, 2017 /PRNewswire/ — Summary
Provides understanding and access to the atherosclerosis partnering deals and agreements entered into by the worlds leading healthcare companies.
Read the full report: http://www.reportlinker.com/p03605675-summary/view-report.html
The Global Atherosclerosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
– Trends in partnering deals
– Top deals by value
– Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this…